Christopher A. Kroeger
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $12.5M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 17SEC | MPLTMapLight Therapeutics, Inc. | Sell | 18,9501,375,144 held (−1%) | $36.00 | $682K | -75.5% |
| Jul 17SEC | MPLTMapLight Therapeutics, Inc. | Sell | 42,7381,332,406 held (−3%) | $36.99 | $1.6M | -76.1% |
| Jul 17SEC | MPLTMapLight Therapeutics, Inc. | Sell | 901,332,316 held (−0%) | $37.54 | $3K | -76.5% |
| Jul 17SEC | MPLTMapLight Therapeutics, Inc. | Sell | 40,8991,291,417 held (−3%) | $36.46 | $1.5M | -75.8% |
| Jul 17SEC | MPLTMapLight Therapeutics, Inc. | Sell | 28,0911,263,326 held (−2%) | $37.26 | $1.0M | -76.3% |
| Jul 17SEC | MPLTMapLight Therapeutics, Inc. | Sell | 921,263,234 held (−0%) | $37.96 | $3K | -76.7% |
| Jul 17SEC | MPLTMapLight Therapeutics, Inc. | Sell | 16,7791,246,455 held (−1%) | $37.90 | $636K | -76.7% |
| May 18SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 118,0371,394,292 held (−8%) | $27.19 | $3.2M | -67.5% |
| May 18SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 1981,394,094 held (−0%) | $28.15 | $6K | -68.6% |
| May 11SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 14,8801,565,940 held (−1%) | $28.47 | $424K | -69.0% |
| May 11SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 5,2201,560,720 held (−0%) | $29.15 | $152K | -69.7% |
| May 11SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 29,6241,531,096 held (−2%) | $27.48 | $814K | -67.9% |
| May 11SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 1,5821,529,514 held (−0%) | $28.56 | $45K | -69.1% |
| May 11SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 3,2051,526,309 held (−0%) | $29.20 | $94K | -69.8% |
| May 11SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 3421,525,967 held (−0%) | $27.57 | $9K | -68.0% |
| May 11SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 8771,525,090 held (−0%) | $28.70 | $25K | -69.2% |
| May 11SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 6,8711,518,219 held (−0%) | $30.04 | $206K | -70.6% |
| May 11SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 5,8901,512,329 held (−0%) | $30.56 | $180K | -71.1% |
| May 6SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 9,1361,621,428 held (−1%) | $27.50 | $251K | -67.9% |
| May 6SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 5,4271,616,001 held (−0%) | $28.37 | $154K | -68.9% |
| May 6SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 3111,615,690 held (−0%) | $29.56 | $9K | -70.1% |
| May 6SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 6971,614,993 held (−0%) | $30.08 | $21K | -70.6% |
| May 6SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 9,5441,605,449 held (−1%) | $28.12 | $268K | -68.6% |
| May 6SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 9281,604,521 held (−0%) | $29.00 | $27K | -69.6% |
| May 6SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 8,0981,596,423 held (−1%) | $28.04 | $227K | -68.5% |
| May 6SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 15,6031,580,820 held (−1%) | $29.13 | $455K | -69.7% |
| Apr 17SEC | MPLTMapLight Therapeutics, Inc. | Sell | 9,1351,640,616 held (−1%) | $26.93 | $246K | -67.2% |
| Apr 17SEC | MPLTMapLight Therapeutics, Inc. | Sell | 2,4771,638,139 held (−0%) | $27.01 | $67K | -67.3% |
| Apr 17SEC | MPLTMapLight Therapeutics, Inc. | Sell | 7,5751,630,564 held (−0%) | $27.49 | $208K | -67.9% |
- Sell
CEO Christopher A. Kroeger sold $3.2M of MPLT at $27.19 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Christopher A. Kroeger sold $6K of MPLT at $28.15 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Christopher A. Kroeger sold $424K of MPLT at $28.47 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Christopher A. Kroeger sold $152K of MPLT at $29.15 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Christopher A. Kroeger sold $814K of MPLT at $27.48 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Christopher A. Kroeger sold $45K of MPLT at $28.56 — pre-scheduled 10b5-1 plan sale.